Physician Assistant in Laconia, NH Accepting Medicare

5 Physician Assistant nurses found. Showing 1 - 5

Michael R Chicoine, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-527-2819    Fax: 603-527-2984

Ms. Leigh Anne Scarmardo, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 85 Spring St, Laconia, NH 03246 Phone: 603-527-2960    Fax: 603-527-2873

Alexandria Colby, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-527-3211

Charlene Kreiensieck, P.A Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 724 N Main St, Laconia, NH 03246 Phone: 603-524-5151

Mirno C Pasquali, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 85 Spring St, Laconia, NH 03246 Phone: 603-527-2955    Fax: 603-527-2947

News Archive

Parkinson's disease discoveries

Genes that affect the immune system and link it to Parkinson's disease have been uncovered. This paves the way for new drug development in Parkinson's disease – a serious, degenerative disease of the nerves that leads to tremors and muscle stiffness and eventually complete loss of movements. There is currently no cure for PD.

Men and women respond very differently to working long hours

Researchers in the UK say that women who work long hours are more likely than men to snack, smoke, drink coffee and exercise less.

Transcept initiates enrollment in TO-2061 Phase 2 study for treatment resistant obsessive compulsive disorder

Transcept Pharmaceuticals, Inc. today announced the first patient has been enrolled in a Phase 2 clinical study to evaluate TO-2061 as an adjunctive treatment for obsessive compulsive disorder (OCD) in patients who have responded inadequately to currently approved treatments. OCD affects 1 to 2 percent of the United States adult population and can significantly impair the lives of patients and their families.

Regulus Therapeutics, sanofi-aventis partner to develop and commercialize microRNA therapeutics

Regulus Therapeutics Inc. and sanofi-aventis announced today that they have entered into a global, strategic alliance to discover, develop, and commercialize microRNA therapeutics. The alliance represents the largest microRNA partnership formed to date, valued at potentially over $750 million, and includes a $25 million upfront fee, a $10 million future equity investment subject to mutual agreement on company valuation, and annual research support for three years with the option to extend two additional years.

Amerigroup reports net income of $48.1 million for third quarter 2011

Amerigroup Corporation today announced that net income for the third quarter of 2011 was $48.1 million, or $0.96 per diluted share, versus net income of $84.3 million, or $1.68 per diluted share, for the third quarter of 2010 and compared to $44.3 million, or $0.83 per diluted share, for the second quarter of 2011.

Read more Medical News

› Verified 9 days ago